E Monastyrska1, W Hagner2, M Jankowski1, I Głowacka3, B Zegarska4, W Zegarski1. 1. Department of Surgical Oncology, Collegium Medicum of the Nicolaus Copernicus University in Torun, Oncology Center in Bydgoszcz, Poland. 2. Department of Rehabilitation, Collegium Medicum of the Nicolaus Copernicus University in Torun, Poland. 3. Department of Rehabilitation, Collegium Medicum of the Nicolaus Copernicus University in Torun, Poland. Electronic address: iwona.glowacka@cm.umk.pl. 4. Department of Dermatology and Cosmetology, Collegium Medicum of the Nicolaus Copernicus University in Torun, Poland.
Abstract
INTRODUCTION: Rectal cancer is the most common malignant neoplasm of the gastrointestinal tract. The aim of the study was to assess the quality of life in patients undergoing surgical treatment for the rectal cancer, either lower anterior or abdominoperineal resection. MATERIALS AND METHODS: 100 patients suffering from rectal cancer were selected for a prospective study (50-APR, 50-LAR). The quality of life was assessed two times: at the admission to the Department and 6 months following surgery. For assessment of the quality of life, two standard questionnaires were used, EORT QLQ-C30 and EORTC QLQ-C29. RESULTS: The studied groups were not different with respect to demographic factors. The patients who underwent LAR spent less time in hospital (p = 0.00001). The patients undergoing APR scored less with respect to physical ability (p = 0.0434), cognitive (p = 0.0363) and emotional state (p = 0.0463) and on symptom scale (nausea and vomiting - p: 0.0199, diarrhea - p: 0.0000, constipation (p = 0.0018)); however, the patients who were treated with LAR scored less on pain scale (p = 0.0189). The QLQ-C29 questionnaire revealed impaired functioning of patients 6 months following APR in terms of life chances (p = 0.0000) and problems with body weight (p = 0.0212). In both groups, the quality of life improved 6 months after surgery. CONCLUSIONS: LAR is a chance for better quality of life for many patients. Six months after surgery, the quality of life of patients improves regardless of the operating method (APR, LAR).
INTRODUCTION:Rectal cancer is the most common malignant neoplasm of the gastrointestinal tract. The aim of the study was to assess the quality of life in patients undergoing surgical treatment for the rectal cancer, either lower anterior or abdominoperineal resection. MATERIALS AND METHODS: 100 patients suffering from rectal cancer were selected for a prospective study (50-APR, 50-LAR). The quality of life was assessed two times: at the admission to the Department and 6 months following surgery. For assessment of the quality of life, two standard questionnaires were used, EORT QLQ-C30 and EORTC QLQ-C29. RESULTS: The studied groups were not different with respect to demographic factors. The patients who underwent LAR spent less time in hospital (p = 0.00001). The patients undergoing APR scored less with respect to physical ability (p = 0.0434), cognitive (p = 0.0363) and emotional state (p = 0.0463) and on symptom scale (nausea and vomiting - p: 0.0199, diarrhea - p: 0.0000, constipation (p = 0.0018)); however, the patients who were treated with LAR scored less on pain scale (p = 0.0189). The QLQ-C29 questionnaire revealed impaired functioning of patients 6 months following APR in terms of life chances (p = 0.0000) and problems with body weight (p = 0.0212). In both groups, the quality of life improved 6 months after surgery. CONCLUSIONS:LAR is a chance for better quality of life for many patients. Six months after surgery, the quality of life of patients improves regardless of the operating method (APR, LAR).
Authors: Mariane Messias Reis Lima Silva; Samuel Aguiar Junior; Juliana de Aguiar Pastore; Érica Maria Monteiro Santos; Fábio de Oliveira Ferreira; Ranyell Matheus S B Spencer; Vinicius F Calsavara; Wilson Toshihiko Nakagawa; Ademar Lopes Journal: Int J Colorectal Dis Date: 2018-04-19 Impact factor: 2.571
Authors: Magdalena Tarkowska; Iwona Głowacka-Mrotek; Bartosz Skonieczny; Michał Jankowski; Tomasz Nowikiewicz; Marcin Jarzemski; Wojciech Zegarski; Piotr Jarzemski Journal: J Clin Med Date: 2022-10-07 Impact factor: 4.964
Authors: Jelle P A Algie; Robert T van Kooten; Rob A E M Tollenaar; Michel W J M Wouters; Koen C M J Peeters; Jan Willem T Dekker Journal: Int J Colorectal Dis Date: 2022-09-26 Impact factor: 2.796
Authors: Samuel Lawday; Nicholas Flamey; George E Fowler; Matthew Leaning; Nadine Dyar; Ian R Daniels; Neil J Smart; Christopher Hyde Journal: BJS Open Date: 2021-11-09